GlassScriptPhysician profile
Reginald M Rousseau
NPI 1306822523
$4,907.45
in general payments reported to CMS, 2019-2025
27 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $288 · 2021: $502 · 2022: $1,075 · 2023: $587 · 2024: $759 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $968.86 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $930.20 | 2019-2025 | Intracept, General - Pain Management |
| Abbott Laboratories | $647.63 | 2019-2025 | Proclaim |
| Medtronic USA, INC. | $527.59 | 2019 | |
| Collegium Pharmaceutical, INC. | $232.15 | 2021-2024 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $194.64 | 2023-2024 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $175.78 | 2020-2024 | Ztlido |
| Globus Medical, INC. | $174.27 | 2025 | Senza |
| Nevro Corp. | $171.66 | 2019-2023 | Senza |
| Nuvasive, INC. | $146.00 | 2022 | |
| Medtronic, INC. | $136.88 | 2022-2024 | Vanta Adaptivestim |
| Spineology INC. | $111.61 | 2019-2021 | |
| Mdd US Operations, LLC | $108.45 | 2019 | |
| Painteq LLC | $45.57 | 2024 | Painteq |
| Biotronik Nro, INC. | $45.32 | 2025 | Prospera |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.30 | 2019-2024 | Relistor |
| Vertex Pharmaceuticals Incorporated | $37.89 | 2025 | |
| Phathom Pharmaceuticals, INC. | $32.27 | 2025 | Voquezna |
| Averitas Pharma INC. | $29.21 | 2024 | Qutenza |
| Janssen Pharmaceuticals, INC | $22.85 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $21.18 | 2020 | |
| Spinal Simplicity, LLC | $20.67 | 2025 | Ha Minuteman G3-R |
| Biodelivery Sciences International, INC. | $19.77 | 2021 | |
| Protega Pharmaceutials INC | $19.62 | 2024 | Roxybond |
| Abbvie INC. | $17.78 | 2023 | Avycaz |
| Chiesi USA, INC. | $14.49 | 2021 | |
| Saluda Medical Americas, INC. | $10.81 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Rousseau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.